Magenta Therapeutics Inc. (MGTA)
NASDAQ: MGTA
· Real-Time Price · USD
0.70
-0.06 (-7.69%)
At close: Sep 11, 2023, 10:00 PM
Magenta Therapeutics Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.02 | -0.02 | -0.03 | -0.04 | -0.05 | -0.18 | -0.02 | -0.01 | -0.06 | -1.02 | -1.86 | -3.37 | -6.12 | -7.76 | -8.22 |
PEG Ratio | 0.00 | 0.00 | -0.00 | n/a | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | 0.04 | -0.1 | -0.34 | 0.98 | 0.70 | 1.56 |
PS Ratio | 2.35 | 0.44 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.01 | 0.04 | 0.52 | 1.13 | 1.51 | 2.25 | 2.59 | 4.46 |
P/FCF Ratio | -0.1 | -0.14 | -0.32 | n/a | n/a | -0.37 | -0.07 | -0.07 | -0.31 | -4.16 | -8.63 | -16.58 | -28.06 | -40.06 | -34.27 |
P/OCF Ratio | -0.1 | -0.14 | -0.32 | n/a | n/a | -0.37 | -0.07 | -0.07 | -0.32 | -4.19 | -8.64 | -16.6 | -30.32 | -40.4 | -34.28 |
OCF/S Ratio | -23.76 | -3.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | 0.28 | 0.25 | 0.23 | 0.21 | n/a | n/a | n/a | n/a |
Quick Ratio | 15.99 | 15.22 | 18.30 | 36.46 | 14.64 | 19.49 | 13.95 | 7.95 | 10.22 | 12.62 | 11.37 | 16.29 | 19.36 | 18.96 | 14.67 |
Current Ratio | 15.99 | 15.22 | 18.30 | 36.46 | 14.64 | 19.49 | 13.95 | 7.95 | 10.22 | 12.62 | 11.37 | 16.29 | 19.36 | 18.96 | 14.67 |
Asset Turnover | 0.00 | 0.02 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -14.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.09 | -0.12 | -0.07 | -0.05 | -0.08 | -0.04 | -0.34 | -0.22 | -0.14 | -0.13 | -0.15 | -0.11 | -0.09 | -0.08 | -0.14 |
Return on Assets | -0.08 | -0.11 | -0.07 | -0.05 | -0.08 | -0.04 | -0.31 | -0.16 | -0.11 | -0.1 | -0.12 | -0.1 | -0.08 | -0.08 | -0.12 |
Return on Invested Capital | -0.1 | -0.29 | -0.09 | -0.06 | -0.09 | -0.1 | 0.04 | -0.18 | -0.12 | -0.11 | -0.13 | -0.11 | -0.09 | -0.08 | -0.14 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -25.37 | -6.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -25.37 | -6.05 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -28.53 | -13.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -28.53 | -5.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |